cognitive cybersecurity intelligence
The UK startup Duke Street Bio has exited stealth mode with funding to develop PARP enzyme inhibitors that treat cancer by blocking the repair of DNA in tumor cells.
London-based Duke Street Bio said Tuesday that it has a portfolio of PARP1 and PARP7 enzyme inhibitors and has raised…
Source: www.labiotech.eu – Read more
Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.
Biopharma has finally begun catching up with the overall stock market, if the positive returns shown by the top three exchange traded funds (ETFs) since
As a research scientist who is devoted to ensuring that immigrant nurses have successful U.S. careers, the issue of internationally educated nurses’ (IENs’) cross-culture language
Students have been sharing with me their reasons for deciding to pursue a career in internal medicine, a fitting topic for this year’s upcoming Internal
Sen. Rand Paul (R-Ky.) called on President Trump to appoint a select group of bipartisan senators to a commission tasked with addressing the expiring health
